TWiV 1010: Clinical update with Dr. Daniel Griffin
In his weekly clinical update, Dr. Griffin discusses the CDC HIV surveillance report, FDA voted in favor of approving the Abrysvo vaccine, canine olfactory detection of SARS-CoV-2-infected humans, saf...
27 Touko 202335min
TWiV 1009: Nidovirus on the water
Vincent travels to Montreux, Switzerland and the 16th International Nidovirus Symposium, where he speaks with Maria von Kerkhove, the face of COVID-19 for the World Health Organization, and Kanta Subb...
21 Touko 20231h 6min
TWiV 1008: Clinical update with Dr. Daniel Griffin
In his weekly clinical update, Dr. Griffin discusses variant specific clinical performance of a SARS-CoV-2 rapid antigen test with focus on omicron VOC, ventilation in buildings, COVID-19 mortality am...
20 Touko 202332min
TWiV 1007: Fragile DNA, viruses, cancer
TWiV explains genetic changes in nOPV2 strains that paralyzed children, outbreak of raccoon distemper in Toronto, EcoHealth Alliance gets its NIH grant back, and breakage at chromosomal fragile sites ...
14 Touko 20231h 40min
TWiV 1006: Clinical update with Dr. Daniel Griffin
In his weekly clinical update, Dr. Griffin discusses immunogenicity and tolerability of a bivalent virus-like particle norovirus vaccine candidate in children from 6 months up to 4 years of age, influ...
13 Touko 202343min
TWiV 1005: COVID T vax and a virus from the blue
TWiV reveals plankton-infecting relatives of herpesviruses in the sunlit oceans, and a vaccine encoding non-spike T cell antigens that protects animals from severe SARS-CoV-2 infection. Hosts: Vincent...
7 Touko 20231h 38min
TWiV 1004: Clinical update with Dr. Daniel Griffin
In his weekly clinical update, Dr. Griffin discusses the U.S. Food and Drug Administration approving Arexvy: the first respiratory syncytial virus (RSV) vaccine approved for use in the United State, a...
6 Touko 202352min
TWiV 1003: Going clinically viral
Vincent and Kathy travel to Atlanta for APHL ID Lab Con, a conference focused on the latest developments in detection and characterization of infectious diseases of public health concern, and speak ...
30 Huhti 20231h 26min
